Revolutionizing immune research with organoid-based co-culture and chip systems

• Published in: Clinical and experimental immunology Vol. 218; no. 1; pp. 40 - 54
• Main Authors: Papp, Diana, Korcsmaros, Tamas, Hautefort, Isabelle
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 16-09-2024
• Subjects: Animals; Coculture Techniques - methods; Humans; Inflammatory Bowel Diseases - immunology; Lab-On-A-Chip Devices; Neoplasms - immunology; Organoids - immunology; Precision Medicine - methods; Review Series - Organoids to Study Immune Cells Development and Function Series Editor: Joana Neves; diseases modeling; immune cells; drug screening; organoids; organ-on-chip; personalized medicine
• ISSN: 0009-9104; 1365-2249; 1365-2249
• DOI: 10.1093/cei/uxae004

The intertwined interactions various immune cells have with epithelial cells in our body require sophisticated experimental approaches to be studied. Due to the limitations of immortalized cell lines and animal models, there is an increasing demand for human in vitro model systems to investigate the microenvironment of immune cells in normal and in pathological conditions. Organoids, which are self-renewing, 3D cellular structures that are derived from stem cells, have started to provide gap-filling tissue modelling solutions. In this review, we first demonstrate with some of the available examples how organoid-based immune cell co-culture experiments can advance disease modelling of cancer, inflammatory bowel disease, and tissue regeneration. Then, we argue that to achieve both complexity and scale, organ-on-chip models combined with cutting-edge microfluidics-based technologies can provide more precise manipulation and readouts. Finally, we discuss how genome editing techniques and the use of patient-derived organoids and immune cells can improve disease modelling and facilitate precision medicine. To achieve maximum impact and efficiency, these efforts should be supported by novel infrastructures such as organoid biobanks, organoid facilities, as well as drug screening and host-microbe interaction testing platforms. All these together or in combination can allow researchers to shed more detailed, and often patient-specific, light on the crosstalk between immune cells and epithelial cells in health and disease.